| LP428185-5 | Specific effective resistance.airway/predicted | COMPONENT | 1 |
| LP428186-3 | Specific effective resistance.airway^pre bronchodilation | COMPONENT | 1 |
| LP428187-1 | Specific effective resistance.airway^post bronchodilation | COMPONENT | 1 |
| LP428188-9 | Specific resistance.airway^pre bronchodilation | COMPONENT | 1 |
| LP428189-7 | Specific resistance.airway^post bronchodilation | COMPONENT | 1 |
| LP428190-5 | Vital capacity/Vital capacity.predicted | COMPONENT | 1 |
| LP428191-3 | Capacity.inspiratory^pre bronchodilation | COMPONENT | 1 |
| LP428192-1 | Capacity.inspiratory^post bronchodilation | COMPONENT | 1 |
| LP428193-9 | Microcystic elongated and fragmented (MELF) invasion pattern | COMPONENT | 1 |
| LP428194-7 | Diffusion capacity.carbon monoxide^pre bronchodilation | COMPONENT | 1 |
| LP428195-4 | Diffusion capacity.carbon monoxide^post bronchodilation | COMPONENT | 1 |
| LP428196-2 | Stromal invasion | COMPONENT | 1 |
| LP428197-0 | Depth of stromal invasion | COMPONENT | |
| LP428198-8 | Omental involvement | COMPONENT | 1 |
| LP428199-6 | Involvement of peritoneal biopsy specimen | COMPONENT | 1 |
| LP428201-0 | Parametrial involvement | COMPONENT | 1 |
| LP428202-8 | Background endometrium findings | COMPONENT | 1 |
| LP428203-6 | Diffusion capacity.carbon monoxide/predicted | COMPONENT | 1 |
| LP428208-5 | Vessels involved in lymphovascular invasion | COMPONENT | 1 |
| LP428209-3 | Cyclic hormonal phase of endometrium | COMPONENT | 1 |
| LP428210-1 | DNA mismatch repair | COMPONENT | 1 |
| LP428211-9 | Structured reporting protocol used | COMPONENT | 1 |
| LP428212-7 | Protocol used for examination of sentinel lymph nodes | COMPONENT | 1 |
| LP428213-5 | Neuroendocrine tumor | COMPONENT | 1 |
| LP428215-0 | Depth of myometrial invasion | COMPONENT | 1 |
| LP428218-4 | Myometrial thickness | DIVISORS | |
| LP428219-2 | Distance of myoinvasive tumor from serosa | COMPONENT | 1 |
| LP428220-0 | Lymphovascular invasion | COMPONENT | |
| LP428221-8 | Lymphovascular invasion extent | COMPONENT | 1 |
| LP428222-6 | Distance of tumor from cervical resection margins | COMPONENT | 1 |
| LP428223-4 | Left pelvic lymph nodes examined | COMPONENT | 1 |
| LP428224-2 | Left pelvic lymph nodes positive | COMPONENT | 1 |
| LP428225-9 | Right pelvic lymph nodes positive | COMPONENT | 1 |
| LP428226-7 | Right pelvic lymph nodes examined | COMPONENT | 1 |
| LP428227-5 | Do you want to talk about contraception or pregnancy prevention during your visit today | COMPONENT | 1 |
| LP428234-1 | Extent of myometrial invasion | COMPONENT | 1 |
| LP428238-2 | Whether the patient previously met the case definition for condition of interest | COMPONENT | 1 |
| LP428239-0 | Spermatozoa.motile^post ejaculation | COMPONENT | 2 |
| LP428240-8 | Spermatozoa^post ejaculation | COMPONENT | 1 |
| LP428242-4 | Spermatozoa motility^post ejaculation | COMPONENT | 1 |
| LP428243-2 | Spermatozoa.agglutinated^post ejaculation | COMPONENT | 2 |
| LP428247-3 | Borrelia burgdorferi IgG and IgM and total panel | COMPONENT | 1 |
| LP428252-3 | Stomach and Duodenum | SYSTEM | 1 |
| LP428253-1 | Fibroblast growth factor 2 | COMPONENT | 1 |
| LP428254-9 | Interleukin 9 | COMPONENT | 1 |
| LP428255-6 | Interleukin 15 | COMPONENT | 1 |
| LP428256-4 | Interleukin 16 | COMPONENT | 1 |
| LP428257-2 | Interleukin 17F | COMPONENT | 1 |
| LP428258-0 | Interleukin 23 | COMPONENT | 1 |
| LP428259-8 | Interleukin 21 | COMPONENT | 1 |